Advertisement

$2.5 M ADB-funded lab equipment, test kits for COVID-19 arrive in Clark

Clark Freeport-- To help capacitate a major regional hospital in Central Luzon in the detection and testing of COVID-19 virus, a $2.5 million laboratory equipment, and 45,000 test kits funded by the Asian Development Bank (ADB) and developed by a genome sequencing company in China arrived in Clark International Airport early morning Wednesday.

LAB EQUIPMENT, TEST KITS ARRIVE IN CLARK. A set of laboratory equipment with 45,000 test kits funded by Asian Development Bank (ADB) and developed by Beijing Genomics Institute (BGI) in China, recently arrived at Clark International Airport. This $2.5 million worth laboratory apparatus will be used to detect and test the presence of the COVID-19 virus. Aside from this, it will also be used to support medical-related researches and training in the future. Meanwhile, the BGI COVID-19 equipment will likewise be instrumental to capacitate Jose B. Lingad Memorial General Hospital (JBLMGH) in Pampanga as a Pandemic Subnational Reference Laboratory in the country. CDC-CD Photo
The laboratory equipment and test kits materials developed by the Beijing Genome Institute (BGI) was picked-up from Shenzhen, China and flown to Clark by a Philippine Air Force C130 cargo plane.

The said lab equipment which can facilitate and has a capacity of 3,000 tests per day will be commissioned and installed at Jose B. Lingad Memorial General Hospital (JBLMGH) at City of San Fernando, Pampanga, making it a Pandemic Subnational Reference Laboratory (PSRL) in the country.

In a report released by the Department of Health (DOH) – Central Luzon posted in their official Facebook page on April 20, it was mentioned that the BGI will assign its own full-time staff in the facility to guide in the preparation of the laboratory. Likewise, BGI personnel will also help in staff training, in commissioning the facility, and in providing technical support during the laboratory’s first week of operations.

As cited in the same report, JBLMGH is now on stage 3 of their accreditation while its personnel are undergoing training from the Research Institute for Tropical Medicine (RITM). The proficiency testing of the equipment and kits on COVID 19 laboratory samples is expected to be conducted on May 2 to 10.

Once the RITM has confirmed the laboratory’s accuracy in testing the samples, it will be certified by May 15 and can run tests on samples at full capacity on May 16.

Aside from its ability to detect and test the presence of the COVID-19 virus, the PSRL in JBLMGH will also be used for supporting medical-related researches on pathogens, genetic disease, and cancer. It will likewise be utilized for training laboratory personnel.

Topics: Asian Development Bank , Beijing Genome Institute , Department of Health , Research Institute for Tropical Medicine
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementGMA-Working Pillars of the House
Advertisement